Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives $5.92 Average Target Price from Analysts
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The […]
Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Get Free Report) have been given an average recommendation of “Moderate Buy” by the six research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The […]
